Literature DB >> 21745501

HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.

Slava Rom1, Marco Pacifici, Giovanni Passiatore, Susanna Aprea, Agnieszka Waligorska, Luis Del Valle, Francesca Peruzzi.   

Abstract

The Src-homology 3 (SH3) domain is one of the most frequent protein recognition modules (PRMs), being represented in signal transduction pathways and in several pathologies such as cancer and AIDS. Grb2 (growth factor receptor-bound protein 2) is an adaptor protein that contains two SH3 domains and is involved in receptor tyrosine kinase (RTK) signal transduction pathways. The HIV-1 transactivator factor Tat is required for viral replication and it has been shown to bind directly or indirectly to several host proteins, deregulating their functions. In this study, we show interaction between the cellular factor Grb2 and the HIV-1 trans-activating protein Tat. The binding is mediated by the proline-rich sequence of Tat and the SH3 domain of Grb2. As the adaptor protein Grb2 participates in a wide variety of signaling pathways, we characterized at least one of the possible downstream effects of the Tat/Grb2 interaction on the well-known IGF-1R/Raf/MAPK cascade. We show that the binding of Tat to Grb2 impairs activation of the Raf/MAPK pathway, while potentiating the PKA/Raf inhibitory pathway. The Tat/Grb2 interaction affects also viral function by inhibiting the Tat-mediated transactivation of HIV-1 LTR and viral replication in infected primary microglia.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745501      PMCID: PMC3527102          DOI: 10.1016/j.bbamcr.2011.06.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  48 in total

Review 1.  Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway.

Authors:  Francesca Peruzzi; Jennifer Gordon; Nune Darbinian; Shohreh Amini
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  The multiple functions of HIV-1 Tat: proliferation versus apoptosis.

Authors:  Francesca Peruzzi
Journal:  Front Biosci       Date:  2006-01-01

Review 3.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

4.  The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.

Authors:  M Lewitzky; C Kardinal; N H Gehring; E K Schmidt; B Konkol; M Eulitz; W Birchmeier; U Schaeper; S M Feller
Journal:  Oncogene       Date:  2001-03-01       Impact factor: 9.867

Review 5.  Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia.

Authors:  Francesca Peruzzi; Valeria Bergonzini; Susanna Aprea; Krzysztof Reiss; Bassel E Sawaya; Jay Rappaport; Shohreh Amini; Kamel Khalili
Journal:  Brain Res Brain Res Rev       Date:  2005-06-03

6.  Epidermal growth factor induces coupling of protein-tyrosine phosphatase 1D to GRB2 via the COOH-terminal SH3 domain of GRB2.

Authors:  L Wong; G R Johnson
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

Review 7.  Endophilin-1: a multifunctional protein.

Authors:  Anne T Reutens; C Glenn Begley
Journal:  Int J Biochem Cell Biol       Date:  2002-10       Impact factor: 5.085

8.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

9.  Sequence alignment reveals possible MAPK docking motifs on HIV proteins.

Authors:  Perry Evans; Ahmet Sacan; Lyle Ungar; Aydin Tozeren
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

10.  Association with Hrs is required for the early endosomal localization, stability, and function of STAM.

Authors:  Emi Mizuno; Kensuke Kawahata; Aya Okamoto; Naomi Kitamura; Masayuki Komada
Journal:  J Biochem       Date:  2004-03       Impact factor: 3.387

View more
  12 in total

1.  The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration.

Authors:  Jerel A Fields; Jeff Metcalf; Cassia Overk; Anthony Adame; Brian Spencer; Wolfgang Wrasidlo; Jazmin Florio; Edward Rockenstein; Johnny J He; Eliezer Masliah
Journal:  J Neurovirol       Date:  2017-01-19       Impact factor: 2.643

2.  Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.

Authors:  Wolf Wrasidlo; Leslie A Crews; Igor F Tsigelny; Emily Stocking; Valentina L Kouznetsova; Diana Price; Amy Paulino; Tania Gonzales; Cassia R Overk; Christina Patrick; Edward Rockenstein; Eliezer Masliah
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

3.  Human immunodeficiency virus protein Tat induces oligodendrocyte injury by enhancing outward K+ current conducted by KV1.3.

Authors:  Han Liu; Jianuo Liu; Enquan Xu; Guihua Tu; Minglei Guo; Shangdong Liang; Huangui Xiong
Journal:  Neurobiol Dis       Date:  2016-11-02       Impact factor: 5.996

Review 4.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

5.  HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.

Authors:  Ferdous Kadri; Marco Pacifici; Anna Wilk; Amanda Parker-Struckhoff; Luis Del Valle; Kurt F Hauser; Pamela E Knapp; Christopher Parsons; Duane Jeansonne; Adam Lassak; Francesca Peruzzi
Journal:  J Biol Chem       Date:  2015-11-03       Impact factor: 5.157

6.  The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity.

Authors:  Slava Rom; Nancy L Reichenbach; Holly Dykstra; Yuri Persidsky
Journal:  Front Microbiol       Date:  2015-08-25       Impact factor: 5.640

7.  Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.

Authors:  Aurélie Cleret-Buhot; Yuwei Zhang; Delphine Planas; Jean-Philippe Goulet; Patricia Monteiro; Annie Gosselin; Vanessa Sue Wacleche; Cécile L Tremblay; Mohammad-Ali Jenabian; Jean-Pierre Routy; Mohamed El-Far; Nicolas Chomont; Elias K Haddad; Rafick-Pierre Sekaly; Petronela Ancuta
Journal:  Retrovirology       Date:  2015-12-10       Impact factor: 4.602

8.  Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease.

Authors:  Monique E Maubert; Brian Wigdahl; Michael R Nonnemacher
Journal:  Front Neurosci       Date:  2017-04-26       Impact factor: 4.677

9.  Cellular levels of Grb2 and cytoskeleton stability are correlated in a neurodegenerative scenario.

Authors:  Piyali Majumder; Kasturi Roy; Brijesh Kumar Singh; Nihar Ranjan Jana; Debashis Mukhopadhyay
Journal:  Dis Model Mech       Date:  2017-03-30       Impact factor: 5.758

10.  Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network.

Authors:  Bi-Qing Li; Bing Niu; Lei Chen; Ze-Jun Wei; Tao Huang; Min Jiang; Jing Lu; Ming-Yue Zheng; Xiang-Yin Kong; Yu-Dong Cai
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.